naltrexone has been researched along with 7-benzylidenenaltrexone in 96 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 47 (48.96) | 18.2507 |
2000's | 35 (36.46) | 29.6817 |
2010's | 12 (12.50) | 24.3611 |
2020's | 2 (2.08) | 2.80 |
Authors | Studies |
---|---|
Nelson, WL; Palmer, RB; Upthagrove, AL | 1 |
Fujii, H; Kobayashi, S; Miyata, Y; Nagase, H; Osa, Y; Takeuchi, T | 1 |
Iwata, S; Koyama, Y; Kutsumura, N; Miyata, Y; Nagase, H; Nagumo, Y; Nakajima, R; Saitoh, T; Yamamoto, N; Yoshida, N | 1 |
Nagase, H; Portoghese, PS; Sultana, M; Takemori, AE | 1 |
Collins, KA; Portoghese, PS; Tsai, JH; Tseng, LF | 1 |
Hammond, DL; Littell, L; Stewart, PE | 1 |
Armstead, WM | 1 |
Funada, M; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Saitoh, A; Suzuki, T | 1 |
Funada, M; Misawa, M; Mori, T; Nagase, H; Suzuki, T | 1 |
Kamei, J; Misawa, M; Mizoguchi, H; Nagase, H; Suzuki, T; Yoshiike, M | 1 |
Misawa, M; Mori, T; Nagase, H; Suzuki, T; Tsuji, M | 2 |
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H | 1 |
Fujimoto, JM; Portoghese, PS; Rady, JJ; Takemori, AE | 1 |
D'Alecy, LG; Mayfield, KP | 2 |
Moe, ST; Portoghese, PS; Sultana, M; Takemori, AE | 1 |
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Suzuki, T | 1 |
Ludbrook, J; Ventura, S | 1 |
Hitosugi, H; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H | 1 |
Portoghese, PS; Takemori, AE | 2 |
Búzás, B; Cox, BM; Izenwasser, S; Portoghese, PS | 1 |
Bowen, WD; Carlisi, VJ; Hruby, VJ; Mosberg, HI; Porreca, F; Portoghese, PS; Sultana, M; Takemori, AE; Wild, KD | 1 |
Portoghese, PS; Sofuoglu, M; Takemori, AE | 1 |
Collins, KA; Portoghese, PS; Tseng, LF | 1 |
Kinter, CM; Lever, JR; Scheffel, U; Stathis, M | 1 |
Mizoguchi, H; Nagase, H; Narita, M; Quock, RM; Suzuki, T; Tseng, LF | 1 |
Endoh, T; Misawa, M; Mori, T; Nagase, H; Suzuki, T; Tsuji, M | 1 |
Mokha, SS; Wang, XM; Yan, JQ; Zhang, KM | 1 |
Fujimoto, J; Ho, BY; Holmes, BB; Zhao, J | 1 |
Baemmert, D; Fujimoto, JM; Portoghese, PS; Rady, JJ; Takemori, AE | 1 |
Khan, S; Smith, ME | 1 |
Hitosugi, H; Kamei, J; Kashiwazaki, T; Nagase, H | 1 |
Dawson-Basoa, M; Gintzler, AR | 2 |
Donahue, BB; Hammond, DL; Stewart, PE | 1 |
Hammond, DL; Thorat, SN | 1 |
Szekeres, PG; Traynor, JR | 1 |
Gross, GJ; Hsu, AK; Schultz, JE | 1 |
Ananthan, S; Riley, ME; Weber, RJ | 1 |
Ohkawa, S; Portoghese, PS | 1 |
Fujimoto, JM; Gorny, JM; Rady, JJ | 1 |
Eells, JT; Fryer, RM; Gross, GJ; Hsu, AK; Nagase, H | 1 |
Hitosugi, H; Kamei, J; Kashiwazaki, T; Nagase, H; Taki, K | 1 |
Gross, GJ; Liang, BT | 1 |
Kamei, J; Nagase, H; Ohsawa, M; Onodera, K; Taki, K | 1 |
Gross, GJ; Huh, J; Liang, BT; Nagase, H | 1 |
Fryer, RM; Gross, GJ; Hsu, AK; Wang, Y | 1 |
Mika, J; Przewłocka, B; Przewłocki, R | 1 |
Fujimoto, JM; Holmes, BB; Rady, JJ; Tseng, LF | 1 |
Brown, DR; Poonyachoti, S; Portoghese, PS | 1 |
Bilsky, EJ; Raehal, KM; Sadée, W; Wang, D | 1 |
Kukreja, RC | 1 |
Gross, GJ; Hsu, A; Moore, J; Patel, HH | 1 |
McPherson, BC; Yao, Z | 1 |
Filliol, D; Gavériaux-Ruff, C; Kieffer, BL; Matthes, HW; Simonin, F | 1 |
Badhwar, V; Bolling, SF; Kilgore, K; Oeltgen, PR; Schwartz, CF; Su, TP | 1 |
Fujimura, T; Hayashi, T; Kastin, AJ; Murayama, K; Narita, M; Orito, T; Sakurada, C; Sakurada, S; Sakurada, T; Suzuki, T; Tan-no, K; Tseng, LF; Yuhki, M; Zadina, JE | 1 |
Bolli, R; Kodani, E; Shinmura, K; Takano, H; Tang, XL; Xuan, YT | 1 |
Broom, DC; Nitsche, JF; Pintar, JE; Rice, KC; Traynor, JR; Woods, JH | 1 |
Caffrey, JL; Farias, M; Jackson, KE; Yoshishige, D | 1 |
Fujita, S; Nakae, Y; Namiki, A | 1 |
Gross, GJ; Peart, JN | 1 |
Lunzer, MM; Portoghese, PS | 2 |
Brown, DR; Townsend, DW | 1 |
Sárváry, L; Schulze, F; Strasser, RH; Weinbrenner, C | 1 |
Cools, AR; Hirose, N; Koshikawa, N; Murakawa, K; Nagase, H; Suzuki, T; Takada, K | 1 |
Agadjanov, MI; Agadjanova, EM; Batikyan, TB; Tadevosyan, YV; Vartanian, GS | 1 |
Bhamidipati, CM; Bilsky, EJ; Blair, JR; Lowery, JJ; Paolino, RM; Raehal, KM; Sadée, W; Wang, D | 1 |
Kamei, J; Onodera, K; Saitoh, A; Yoshikawa, Y | 1 |
Cools, AR; Hirose, N; Koshikawa, N; Murakawa, K; Nagase, H; Oi, Y; Suzuki, T; Takada, K | 1 |
Castro, MS; Duarte, ID; Francischi, JN; Pacheco, DF; Perez, AC; Reis, GM | 1 |
Chang, KJ; Gengo, PJ; Gross, GJ; Holt, JD; O'Neill, SJ; Pendergast, W; Watson, MJ; Wei, K | 1 |
Kamei, J; Miyata, S; Saitoh, A; Takahashi, M | 1 |
Barlow, MA; Caffrey, JL; Deo, SH; Johnson-Davis, S; Yoshishige, D | 1 |
Barlow, M; Caffrey, JL; Davis, S; Deo, SH; Farias, M; Yoshishige, D | 1 |
Sadee, W; Sun, X; Wang, D | 1 |
Dimitrijević, M; Kovacević-Jovanović, V; Kustrimović, N; Miletić, T; Mitić, K; Stanojević, S; Vujić, V | 1 |
Arout, CA; Inturrisi, CE; Juni, A; Kest, B; Klein, G; Waxman, AR | 1 |
Chefer, VI; Shippenberg, TS; Thompson, AC | 1 |
Barzakh, EI; Chernysheva, GA; Cybulnikov, SY; Krieg, T; Krylatov, AV; Lishmanov, AY; Maslov, LN; Solenkova, NV; Zhang, Y | 1 |
Fujii, H; Kobayashi, S; Miyata, Y; Nagase, H; Takeuchi, T; Uenohara, Y | 1 |
Harvey, JH; van Rijn, RM; Whistler, JL | 1 |
Nagase, H; Oka, J; Saitoh, A; Sugiyama, A; Yamada, M | 1 |
Jiang, S; Liu, Z; Song, L; Wang, L; Wang, W; Zhang, R; Zhou, Z | 1 |
Beaudry, H; Gendron, L; Morón, JA | 1 |
Fujii, H; Iwata, S; Koyama, Y; Kutsumura, N; Miyata, Y; Nagase, H; Nakajima, R; Saitoh, T; Yamamoto, N | 1 |
Chung, HK; Lamb, K; Lin, MZ; Plemper, RK; Weisshaar, M; Yan, D | 1 |
Asahi, H; Inoue, SI; Kobayashi, F; Kunigo, K; Niikura, M; Sendo, F; Suzuki, Y | 1 |
Chuang, EY; Hsiao, YW; Huang, DY; Hwai, H; Jhou, JP; Lai, LC; Tseng, TC; Tzeng, SJ | 1 |
Hokari, R; Ishiyama, A; Iwatsuki, M; Koyama, Y; Kutsumura, N; Miyata, Y; Nagase, H; Nagumo, Y; Ōmura, S; Otoguro, K; Saitoh, T; Yamamoto, N | 1 |
Maslov, LN; Naryzhnaya, NV; Nesterov, EA; Prokudina, ES; Tsibulnikov, SY | 1 |
Bell, GI; Chen, Y; Kong, H; Raynor, K; Reisine, T; Yasuda, K; Yu, L | 1 |
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A | 1 |
96 other study(ies) available for naltrexone and 7-benzylidenenaltrexone
Article | Year |
---|---|
(E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
Topics: Animals; Benzeneacetamides; Benzomorphans; Benzylidene Compounds; Binding, Competitive; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Guinea Pigs; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Conformation; Molecular Structure; Naltrexone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, delta; Spectroscopy, Fourier Transform Infrared | 1997 |
Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi.
Topics: Antimalarials; Benzylidene Compounds; Chloroquine; Drug Resistance; Molecular Structure; Naltrexone; Parasitic Sensitivity Tests; Plasmodium chabaudi; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2011 |
Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives.
Topics: Animals; Antitrichomonal Agents; Benzylidene Compounds; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Molecular Structure; Naltrexone; Receptors, Opioid, delta; Structure-Activity Relationship; Trichomonas vaginalis | 2017 |
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
Topics: Animals; Benzylidene Compounds; Guinea Pigs; In Vitro Techniques; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta | 1992 |
Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat.
Topics: Amino Acid Sequence; Analgesia; Animals; Benzylidene Compounds; beta-Endorphin; Dose-Response Relationship, Drug; Enkephalin, Methionine; Injections, Intraventricular; Injections, Spinal; Male; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Pentobarbital; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Spinal Cord; Tail | 1995 |
Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Topics: Analgesics; Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Spinal Cord | 1995 |
The contribution of delta 1- and delta 2-opioid receptors to hypoxia-induced pial artery dilation in the newborn pig.
Topics: Animals; Animals, Newborn; Benzylidene Compounds; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Female; Hypoxia; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Pia Mater; Receptors, Opioid, delta; Receptors, Opioid, mu; Swine; Vasodilation | 1995 |
Effects of diabetes on spontaneous locomotor activity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzylidene Compounds; Brain; Corpus Striatum; Diabetes Mellitus, Experimental; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice; Mice, Inbred ICR; Motor Activity; Naltrexone; Narcotic Antagonists; Prosencephalon; Receptors, Dopamine D1; Receptors, Opioid, delta; Reference Values | 1994 |
Attenuation of the discriminative stimulus properties of cocaine by delta-opioid receptor antagonists.
Topics: Animals; Benzylidene Compounds; Cocaine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Naltrexone; Rats; Rats, Inbred F344; Receptors, Opioid, delta | 1994 |
Blockade of delta-opioid receptors prevents morphine-induced place preference in mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Conditioning, Operant; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Mice, Inbred Strains; Morphine; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, delta; Receptors, Opioid, mu | 1994 |
The role of delta-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences.
Topics: Animals; Benzylidene Compounds; Cocaine; Conditioning, Psychological; Male; Methamphetamine; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reinforcement, Psychology | 1994 |
Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors.
Topics: Analgesia; Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Naltrexone; Oligopeptides; Receptors, Opioid, delta; Receptors, Opioid, mu; Streptozocin | 1994 |
Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice.
Topics: Animals; Benzylidene Compounds; Heroin; Male; Mice; Morphine Derivatives; Naltrexone; Pain; Receptors, Opioid, delta | 1994 |
Delta-1 opioid agonist acutely increases hypoxic tolerance.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adaptation, Physiological; Animals; Benzylidene Compounds; Body Temperature; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Hypoxia; Male; Mice; Naltrexone; Pyrrolidines; Receptors, Opioid, delta | 1994 |
Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.
Topics: Animals; Benzylidene Compounds; Electric Stimulation; Guinea Pigs; Ileum; Male; Mice; Models, Molecular; Molecular Conformation; Molecular Structure; Muscle, Smooth; Naltrexone; Receptors, Opioid, delta; Structure-Activity Relationship; Vas Deferens | 1994 |
Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists.
Topics: Animals; Antitussive Agents; Benzylidene Compounds; Capsaicin; Cough; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta | 1994 |
The decompensatory phase of acute hypovolaemia in rabbits involves a central delta 1-opioid receptor.
Topics: Animals; Benzylidene Compounds; Blood Pressure; Cardiac Output; Enkephalin, Leucine; Hemodynamics; Hemorrhage; Naltrexone; Narcotic Antagonists; Rabbits; Receptors, Opioid, delta; Shock | 1994 |
Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice.
Topics: Analgesia; Animals; Benzylidene Compounds; Cold Temperature; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; Naltrexone; Receptors, Opioid, delta; Streptozocin; Stress, Physiological; Swimming | 1994 |
Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively.
Topics: Animals; Benzylidene Compounds; beta-Endorphin; Brain; Enkephalin, Leucine; Enkephalin, Methionine; Injections, Intraventricular; Injections, Spinal; Male; Mice; Naltrexone; Pain; Receptors, Opioid, delta; Spinal Cord | 1993 |
Delta-1 opioid receptor dependence of acute hypoxic adaptation.
Topics: Adaptation, Physiological; Animals; Benzylidene Compounds; Hypoxia; Male; Mice; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta | 1994 |
Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Analgesics; Animals; Benzylidene Compounds; Caudate Nucleus; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalins; Male; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 1994 |
Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
Topics: Animals; Benzylidene Compounds; Drug Tolerance; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; In Vitro Techniques; Isothiocyanates; Male; Mice; Mice, Inbred ICR; Morphinans; Naltrexone; Oligopeptides; Receptors, Opioid, delta; Thiocyanates; Vas Deferens | 1993 |
7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
Topics: Analgesics; Animals; Benzylidene Compounds; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, delta; Spinal Cord | 1993 |
Spinal delta 2 but not delta 1 opioid receptors are involved in intracerebroventricular beta-endorphin-induced antinociception in the mouse.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzylidene Compounds; beta-Endorphin; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Pain Measurement; Pyrrolidines; Receptors, Opioid, delta; Spinal Cord | 1993 |
The mixed antinociceptive agonist-antagonist activity of beta-endorphin(1-27) in mice.
Topics: Animals; Benzylidene Compounds; beta-Endorphin; Male; Mice; Naltrexone; Narcotic Antagonists; Nociceptors; Peptide Fragments; Receptors, Opioid | 1993 |
In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype.
Topics: Animals; Benzylidene Compounds; Corpus Striatum; Male; Mice; Naltrexone; Radioligand Assay; Receptors, Opioid, delta; Tritium | 1996 |
Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity.
Topics: Amino Acid Sequence; Analysis of Variance; Animals; Base Sequence; Benzylidene Compounds; Cerebral Ventricles; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Motor Activity; Naltrexone; Narcotic Antagonists; Oligonucleotides, Antisense; Oligopeptides; Receptors, Opioid, delta; Somatostatin; Thionucleotides | 1996 |
Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Dopamine; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Limbic System; Male; Mice; Morphine; Naltrexone; Quinolines; Receptors, Opioid, delta; Reward | 1996 |
Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
Topics: Animals; Benzylidene Compounds; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Evoked Potentials; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Fibers; Neurons; Nociceptors; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Trigeminal Caudal Nucleus | 1996 |
Determination of delta-opioid in NG108-15 cells.
Topics: Animals; Benzylidene Compounds; Cyclic AMP; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalins; Glioma; Mice; Naltrexone; Neuroblastoma; Rats; Receptors, Opioid, delta; Tumor Cells, Cultured | 1997 |
Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; beta-Endorphin; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Male; Mice; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Spinal Cord | 1997 |
Actions of beta-endorphin peptides on the contractions of mouse diaphragm muscle.
Topics: Animals; Benzylidene Compounds; beta-Endorphin; Diaphragm; Dipeptides; Electric Stimulation; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Female; Mice; Mice, Inbred C57BL; Muscle Contraction; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Neostigmine; Oligopeptides; Peptide Fragments | 1997 |
The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Spinal Cord | 1997 |
Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation.
Topics: Animals; Benzylidene Compounds; Female; Humans; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Pain; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Sensory Thresholds; Sex Characteristics; Spinal Cord; Time Factors | 1997 |
The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine.
Topics: Animals; Benzylidene Compounds; Central Nervous System Stimulants; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Methamphetamine; Naltrexone; Quinolines; Rats; Rats, Inbred F344; Receptors, Opioid, delta | 1997 |
Role of spinal delta1 and delta2 opioid receptors in the antinociception produced by microinjection of L-glutamate in the ventromedial medulla of the rat.
Topics: Analgesics; Animals; Benzylidene Compounds; Glutamic Acid; Isothiocyanates; Male; Medulla Oblongata; Microinjections; Naltrexone; Narcotic Antagonists; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Spinal Cord | 1997 |
Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Medulla Oblongata; Microinjections; Naltrexone; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 1997 |
Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
Topics: Animals; Benzylidene Compounds; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalins; Guanosine 5'-O-(3-Thiotriphosphate); Mice; Naltrexone; Neuroblastoma; Rats; Receptors, Opioid, delta; Sodium | 1997 |
Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors.
Topics: Animals; Benzylidene Compounds; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1998 |
Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems.
Topics: Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Estrogens; Female; Naltrexone; Narcotic Antagonists; Ovary; Pain Threshold; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Spinal Cord | 1998 |
Novel non-peptidic opioid compounds with immunopotentiating effects.
Topics: Adjuvants, Immunologic; Animals; Benzylidene Compounds; Cell Division; Male; Naltrexone; Narcotics; Rats; Rats, Inbred F344; Somatostatin; Structure-Activity Relationship; T-Lymphocytes | 1998 |
7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.
Topics: Animals; Benzylidene Compounds; Electric Stimulation; Guinea Pigs; Ileum; In Vitro Techniques; Ligands; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Muscle, Smooth; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Structure-Activity Relationship; Tail; Vas Deferens | 1998 |
Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.
Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Heroin; Injections, Intraventricular; Male; Mice; Morphine; Morphine Derivatives; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Receptors, Opioid, delta; Receptors, Opioid, mu; Streptozocin; Time Factors | 1998 |
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels.
Topics: Analgesics; Animals; Benzylidene Compounds; Blood Pressure; Coronary Circulation; Glyburide; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Male; Mitochondria; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Potassium Channels; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta | 1999 |
Algogenic mediator-induced nociceptive response in diabetic mice.
Topics: Animals; Benzylidene Compounds; Bradykinin; Diabetes Mellitus, Experimental; Dinoprost; Dose-Response Relationship, Drug; Formaldehyde; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain; Receptors, Opioid, delta; Somatostatin | 1999 |
Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels.
Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Anti-Arrhythmia Agents; Benzylidene Compounds; Cells, Cultured; Chick Embryo; Decanoic Acids; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Morphine; Muscle Fibers, Skeletal; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Potassium Channels; Receptors, Opioid | 1999 |
Involvement of spinal delta 1-opioid receptors in forced walking stress-induced antinociception in the tail-flick test in mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Stress, Physiological; Time Factors; Walking | 1999 |
Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Benzylidene Compounds; Cells, Cultured; Chick Embryo; Enzyme Inhibitors; Glyburide; Heart; Ischemia; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardium; Naltrexone; Narcotic Antagonists; Phenanthridines; Potassium Channel Blockers; Protein Kinase C; Quinolines | 2001 |
Essential activation of PKC-delta in opioid-initiated cardioprotection.
Topics: Acetophenones; Alkaloids; Analgesics; Animals; Benzophenanthridines; Benzopyrans; Benzylidene Compounds; Enkephalin, Leucine-2-Alanine; Enzyme Activation; Enzyme Inhibitors; Heart Rate; Indoles; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Maleimides; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Phenanthridines; Protein Kinase C; Protein Kinase C-delta; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta | 2001 |
The role of delta-opioid receptor subtypes in neuropathic pain.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Benzylidene Compounds; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Isothiocyanates; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Oligopeptides; Pain Measurement; Protein Isoforms; Rats; Rats, Wistar; Receptors, Opioid, delta; Sciatic Nerve; Time Factors | 2001 |
Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Cholecystokinin; Drug Tolerance; Enkephalin, Leucine; Excitatory Amino Acid Agonists; Male; Mice; Morphine; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Spinal Cord | 2001 |
Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
Topics: Animals; Benzylidene Compounds; Electric Stimulation; Epithelium; Evoked Potentials; Female; Immunohistochemistry; In Vitro Techniques; Intestinal Mucosa; Male; Microscopy, Confocal; Naltrexone; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Swine | 2001 |
Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Cell Line; Cell Membrane; Cyclic AMP; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kidney; Magnesium; Male; Mice; Mice, Inbred ICR; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Receptors, Opioid, mu; Signal Transduction; Substance Withdrawal Syndrome; Sulfur Radioisotopes; Transfection; Tritium | 2001 |
Essential role of oxygen radicals in delayed pharmacological preconditioning.
Topics: Animals; Antioxidants; Benzamides; Benzylidene Compounds; Dose-Response Relationship, Drug; Drug Therapy, Combination; Free Radicals; Humans; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Oxygen; Piperazines; Quinolines; Rats; Receptors, Opioid, delta; Tiopronin | 2001 |
BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation.
Topics: Animals; Antioxidants; Benzamides; Benzylidene Compounds; Dose-Response Relationship, Drug; Free Radicals; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardial Reperfusion; Naltrexone; Narcotic Antagonists; Piperazines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Tiopronin | 2001 |
Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion.
Topics: Animals; ATP-Binding Cassette Transporters; Benzamides; Benzylidene Compounds; Cell Survival; Chick Embryo; Decanoic Acids; Free Radicals; Hydroxy Acids; KATP Channels; Myocardial Reperfusion Injury; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Oxidative Stress; Piperazines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Opioid, delta; Signal Transduction | 2001 |
Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity.
Topics: Animals; Benzylidene Compounds; Cell Division; Concanavalin A; Dipeptides; Immunosuppressive Agents; Interleukin-2; Lymphocyte Culture Test, Mixed; Lymphocytes; Mice; Mice, Knockout; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, sigma; T-Lymphocytes; Tetrahydroisoquinolines | 2001 |
Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Cardiac Surgical Procedures; Coronary Circulation; Disease Models, Animal; Drug Evaluation, Preclinical; Enkephalin, D-Penicillamine (2,5)-; Heart Arrest, Induced; Hypothermia, Induced; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Organ Size; Oxygen Consumption; Rabbits; Receptors, Opioid, delta; Recovery of Function; Stroke Volume; Ventricular Pressure | 2001 |
Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Topics: Analgesics; Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Methionine; Immune Sera; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptide Fragments; Time Factors | 2001 |
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Benzylidene Compounds; Celecoxib; Consciousness; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Heart Rate; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Myocardial Infarction; Myocardial Stunning; Myocardium; Naltrexone; Narcotic Antagonists; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Opioid, delta; Sulfonamides | 2002 |
Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzamides; Benzylidene Compounds; Convulsants; Drug Tolerance; Enkephalin, D-Penicillamine (2,5)-; Male; Mice; Mice, Knockout; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta | 2002 |
Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzylidene Compounds; Bradycardia; Dogs; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Methionine; Naltrexone; Narcotic Antagonists; Oligopeptides; Opioid Peptides; Quinolines; Receptors, Opioid, delta; Sinoatrial Node; Vagus Nerve | 2003 |
Modulation of myofilament Ca2+ densitivity by delta- and kappa-opioid agonists in intact guinea pig hearts.
Topics: Actin Cytoskeleton; Animals; Benzylidene Compounds; Blood Pressure; Calcium; Coronary Circulation; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Kinetics; Naltrexone; Narcotic Antagonists; Pyrrolidines; Quinolines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Stimulation, Chemical; Ventricular Function, Left | 2003 |
Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors.
Topics: Adenosine; Analgesics, Opioid; Animals; ATP-Binding Cassette Transporters; Benzylidene Compounds; Free Radicals; Heart Diseases; In Vitro Techniques; KATP Channels; Mitochondria, Heart; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Naltrexone; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Opioid, delta; Receptors, Purinergic P1 | 2003 |
Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord.
Topics: Animals; Benzylidene Compounds; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Immune Sera; Mice; Naltrexone; Oligopeptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Spinal Cord | 2003 |
Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa.
Topics: Amphibian Proteins; Animals; Anions; Benzamides; Benzylidene Compounds; Biological Transport, Active; Carrier Proteins; Diprenorphine; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Female; Gastrointestinal Motility; Ileum; Intestinal Mucosa; Male; Naltrexone; Neurons, Afferent; Oligopeptides; Piperazines; Quinolines; Receptors, Opioid, delta; Receptors, Opioid, mu; Swine; Tritium | 2003 |
Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Benzylidene Compounds; Free Radical Scavengers; Free Radicals; Glycine; Ischemic Preconditioning, Myocardial; Ligation; Male; Myocardial Infarction; Myocardium; Naltrexone; Rats; Rats, Wistar; Receptors, Opioid, delta; Signal Transduction; Sulfhydryl Compounds | 2004 |
Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Benzylidene Compounds; Dopamine; Extracellular Space; Male; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Somatostatin; Tetrodotoxin; Time Factors | 2004 |
Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus.
Topics: Benzylidene Compounds; Diabetes Mellitus; Diglycerides; Humans; In Vitro Techniques; Lymphocytes; Naltrexone; Oligopeptides; Phosphatidylinositols; Receptors, Opioid, delta; Signal Transduction | 2004 |
In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
Topics: Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2005 |
Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.
Topics: Animals; Anxiety; Benzamides; Benzylidene Compounds; Blood Specimen Collection; Corticosterone; Male; Maze Learning; Naltrexone; Piperazines; Rats; Rats, Inbred Lew; Receptors, Opioid, delta | 2005 |
Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Topics: Analgesics, Opioid; Anesthetics, Local; Animals; Benzylidene Compounds; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Extracellular Space; Male; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Tetrodotoxin | 2005 |
delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Topics: Analgesics; Animals; Arginine; Benzamides; Benzylidene Compounds; Cyclic GMP; Dinoprostone; Enzyme Inhibitors; Hyperalgesia; Male; Naltrexone; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Piperazines; Rats; Receptors, Opioid, delta | 2005 |
ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
Topics: Animals; Benzoates; Benzylidene Compounds; Binding, Competitive; Cardiotonic Agents; Catalepsy; Dose-Response Relationship, Drug; Hemodynamics; In Vitro Techniques; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reflex; Seizures | 2006 |
Involvement of delta1-opioid receptors in the spatial learning impairment in streptozotocin-induced diabetic mice.
Topics: Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Enkephalins; Escape Reaction; Mice; Naltrexone; Reaction Time; Receptors, Opioid, delta; Space Perception | 2005 |
Repeated delta1-opioid receptor stimulation reduces delta2-opioid receptor responses in the SA node.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzylidene Compounds; Bradycardia; Dogs; Dose-Response Relationship, Drug; Enkephalin, Methionine; Female; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Oligopeptides; Quinolines; Receptors, Opioid, delta; Sinoatrial Node; Stimulation, Chemical; Vagus Nerve | 2006 |
The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of delta2-opioid receptor stimulation.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Bradycardia; Dogs; Dose-Response Relationship, Drug; Enkephalin, Methionine; Female; G(M1) Ganglioside; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, delta; Sinoatrial Node; Stimulation, Chemical; Vagus Nerve | 2006 |
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Topics: Benzylidene Compounds; Cells, Cultured; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Morphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Signal Transduction | 2007 |
Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzylidene Compounds; Enkephalin, D-Penicillamine (2,5)-; Injections, Intraventricular; Injections, Spinal; Ligands; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, kappa | 2007 |
Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors.
Topics: Animals; Benzylidene Compounds; Carcinogens; Dose-Response Relationship, Drug; Enkephalin, Methionine; Hydrogen Peroxide; Macrophages, Peritoneal; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tetradecanoylphorbol Acetate | 2008 |
Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.
Topics: Acute Disease; Animals; Behavior, Animal; Benzylidene Compounds; Chronic Disease; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Heroin Dependence; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors | 2008 |
Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.
Topics: Analysis of Variance; Animals; Association Learning; Behavior, Animal; Benzylidene Compounds; Conditioning, Classical; Disease Models, Animal; Male; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, Opioid, delta; Receptors, Opioid, mu; Reinforcement, Psychology; Statistics, Nonparametric | 2009 |
Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels.
Topics: Animals; Benzophenanthridines; Benzylidene Compounds; Decanoic Acids; Glyburide; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Naltrexone; Oligopeptides; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Receptors, Opioid, delta | 2010 |
Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi.
Topics: Antimalarials; Benzylidene Compounds; Chloroquine; Drug Resistance; Glutathione Reductase; Naltrexone; Plasmodium chabaudi | 2012 |
A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers.
Topics: Benzylidene Compounds; Calcium Signaling; Cell Culture Techniques; Drug Evaluation, Preclinical; Enkephalin, D-Penicillamine (2,5)-; HEK293 Cells; High-Throughput Screening Assays; Humans; Naltrexone; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Recombinant Proteins; Spectrometry, Fluorescence; Transfection | 2013 |
DOR(2)-selective but not DOR(1)-selective antagonist abolishes anxiolytic-like effects of the δ opioid receptor agonist KNT-127.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzylidene Compounds; Exploratory Behavior; Formaldehyde; Male; Maze Learning; Morphinans; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Nociception; Rats; Rats, Wistar; Receptors, Opioid, delta | 2014 |
The immunomodulation mediated by a delta-opioid receptor for [Met(5)]-enkephalin in oyster Crassostrea gigas.
Topics: Amino Acid Sequence; Animals; Benzylidene Compounds; Calcium; Cell Line; Cloning, Molecular; Crassostrea; Cyclic AMP; DNA, Complementary; Enkephalin, Methionine; HEK293 Cells; Hepatopancreas; Humans; Lipopolysaccharides; Molecular Sequence Data; Naltrexone; Phagocytosis; Receptors, Opioid, delta; RNA, Messenger; Sequence Alignment; Signal Transduction; Vibrio | 2015 |
Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Freund's Adjuvant; Hindlimb; Inflammation; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats, Sprague-Dawley; Receptors, Opioid, delta | 2015 |
Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound.
Topics: Antitrichomonal Agents; Benzylidene Compounds; Dose-Response Relationship, Drug; Female; Humans; Molecular Structure; Naltrexone; Receptors, Opioid, delta; Structure-Activity Relationship; Trichomonas Vaginitis | 2015 |
Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
Topics: Animals; Antiviral Agents; Benzylidene Compounds; Cell Line; Coinfection; Dogs; Dose-Response Relationship, Drug; Feasibility Studies; Fenretinide; Genes, Reporter; High-Throughput Screening Assays; Humans; Influenza A virus; Luciferases, Firefly; Luciferases, Renilla; Naltrexone; Narcotic Antagonists; Neuraminidase; Respiratory Syncytial Viruses; Ribavirin; Virus Internalization; Virus Replication; Zanamivir | 2015 |
Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Benzylidene Compounds; Camphanes; Cannabinoid Receptor Antagonists; Cell Death; Chromatin; Dose-Response Relationship, Drug; Gene Expression Profiling; Glutathione; Naltrexone; Narcotic Antagonists; Oxidation-Reduction; Piperidines; Plasmodium falciparum; Pyrazoles; Rimonabant; Transcriptome | 2017 |
Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1.
Topics: Animals; Autoantibodies; B-Lymphocytes; Benzylidene Compounds; Cell Line; Female; GPI-Linked Proteins; Heme Oxygenase-1; Kidney; Lupus Nephritis; Membrane Proteins; Mice, Inbred MRL lpr; Naltrexone; Receptors, IgG; Spleen | 2018 |
Structure-Activity Relationship between Thiol Group-Trapping Ability of Morphinan Compounds with a Michael Acceptor and Anti-
Topics: Antimalarials; Benzylidene Compounds; Humans; Morphinans; Naltrexone; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Structure-Activity Relationship | 2020 |
The Role of Cardiac Opioid Receptors in the Cardioprotective Effect of Continuous Normobaric Hypoxia.
Topics: Adaptation, Physiological; Animals; Benzylidene Compounds; Creatine Kinase; Hypoxia; Male; Myocardial Reperfusion Injury; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Organ Culture Techniques; Peptides; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tetrahydroisoquinolines | 2020 |
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
Topics: Analgesics; Animals; Binding Sites; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Ligands; PC12 Cells; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Software | 1994 |
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders | 1998 |